A carregar...
Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data
BACKGROUND: The aim of this study was to analyse registry data of seizure outcome and adverse events (AEs) for perampanel as add-on therapy in patients with focal epilepsy since its approval in 2012 for adjunctive treatment of focal epilepsy in patients ⩾12 years. METHOD: A retrospective 2-year char...
Na minha lista:
Publicado no: | Ther Adv Neurol Disord |
---|---|
Main Authors: | , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
SAGE Publications
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066528/ https://ncbi.nlm.nih.gov/pubmed/27800020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616661115 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|